Table 3.
Comparison of circulating EPCs levels between diabetics and nondiabetics
| Non-diabetics (n = 62) | Type 2 diabetics (n = 38) | p value | |
|---|---|---|---|
| Time from PCI to blood sampling (hours) |
13.8 ± 14.7 |
11.6 ± 11.7 |
0.649 |
| CD34+ cells/106 WBC |
228.8 ± 136.7 |
197.0 ± 115.2 |
0.098 |
| CD133+/106 WBC |
54.4 ± 35.7 |
36.0 ± 18.0 |
0.020 |
| CD45dimCD34+KDR+ cells/106 WBC |
6.2 ± 3.0 |
2.3 ± 0.9 |
<0.001 |
| CD45dimCD34+KDR+CXCR4+ cells/106 WBC |
1.8 ± 1.1 |
0.8 ± 0.7 |
<0.001 |
| CD45dimCD34+CD133+KDR+ cells/106 WBC |
2.1 ± 1.1 |
1.0 ± 0.8 |
<0.001 |
| CD133+KDR+/106 WBC |
4.6 ± 2.9 |
3.1 ± 1.6 |
<0.001 |
| CD133+KDR+CXCR4+/106 WBC | 3.5 ± 1.9 | 2.0 ± 1.2 | <0.001 |
PCI, percutaneous coronary intervention; WBC, white blood cells.